Women in clinical trials: a review of policy development and health equity in the Canadian context

dc.contributor.authorYakerson, Alla
dc.date.accessioned2020-03-11T15:59:55Z
dc.date.available2020-03-11T15:59:55Z
dc.date.issued2019-04-15
dc.description.abstractHealth equity in pharmaceutical research is concerned with creating equal opportunities for men and women to partake in clinical trials. Equitable representation is imperative for determining the safety, effectiveness, and tolerance of drugs for all consumers. Historically, women have been excluded from participating in clinical research leading to a lack of knowledge regarding drug effects and their consequences. This paper examines the changes made since the implementation of Canadian policies on the representation of women in clinical trials, the analysis of sex and gender, as well as the discourses that are prominent among researchers. A feminist ethics framework is used to examine the structures that endeavor to elucidate women’s involvement in trials, as experienced under extensive patriarchal history. Scholarly literature and Canadian government policy documents are used to explore the development of clinical trials as pertaining to sex and gender. Findings suggest that women continue to be underrepresented or excluded from important research, highlighting ongoing ethical and justice concerns. Improvement recommendations for policies are outlined. Keywords: Women, Clinical trials, Underrepresentation, Feminism, Sex, Gender, Policyen_US
dc.description.sponsorshipYork University Librariesen_US
dc.identifier.citationInternational Journal for Equity in Health 18 (2019): 56.en_US
dc.identifier.urihttps://doi.org/10.1186/s12939-019-0954-xen_US
dc.identifier.urihttps://hdl.handle.net/10315/37094
dc.language.isoenen_US
dc.publisherBiomed Centralen_US
dc.rightsAttribution 2.5 Canada*
dc.rights.articlehttps://equityhealthj.biomedcentral.com/articles/10.1186/s12939-019-0954-xen_US
dc.rights.journalhttps://equityhealthj.biomedcentral.com/en_US
dc.rights.publisherhttps://www.biomedcentral.com/en_US
dc.rights.urihttp://creativecommons.org/licenses/by/2.5/ca/*
dc.subjectWomenen_US
dc.subjectClinical trialsen_US
dc.subjectUnderrepresentationen_US
dc.subjectFeminismen_US
dc.subjectSexen_US
dc.subjectGenderen_US
dc.subjectPolicyen_US
dc.titleWomen in clinical trials: a review of policy development and health equity in the Canadian contexten_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
s12939-019-0954-x.pdf
Size:
606.62 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.83 KB
Format:
Item-specific license agreed upon to submission
Description: